Stay updated with breaking news from 4basebio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
4basebio Plc - Joint Development Agreement with Leucid Bio PR Newswire London, November 22 23 November 2021 4basebio PLC ("4basebio", the "Company" or the "Group") Joint
4basebio UK Societas Notice of Annual General Meeting Posting of Annual Report and Financial Statements 4basebio UK Societas , the specialist life sciences group focused on... | June 4, 2021
4basebio UK Societas - Holding(s) in Company PR Newswire NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii 4basebio UK Societas 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer An acquisition or disposal of voting rights An acquisition or disposal of financial instruments An event changing the breakdown of voting rights x iv Heidelberg, Germany v
4basebio UK Societas - Admission to Trading on AIM and First Day of Dealings PR Newswire Admission to Trading on AIM and First Day of Dealings 4basebio UK Societas (AIM: 4BB), the specialist life sciences group focused on exploiting its intellectual property in the field of gene therapies and DNA vaccines, is pleased to announce the admission of its ordinary shares to trading on the AIM market of the London Stock Exchange. Dealings will commence at 8.00 a.m. today, Wednesday 17 February 2021, under the ticker 4BB (ISIN GB00BLD8ZL39). Upon Admission, the Company will have 12,317,473 ordinary s...